Central serous chorioretinopathy (CSC) is a common cause of central vision loss, primarily
affecting men 20–60 years of age. To date, no consensus has been reached regarding the …

Recent technological advances—new pathophysiological insights, new imaging techniques
for diagnosis and management, and new treatments—have led to an improved …

Central serous chorioretinopathy (CSC) is a relatively common disease that causes vision
loss due to macular subretinal fluid leakage and is often associated with reduced vision …

Review and update of central serous chorioretinopathy : Current Opinion in Ophthalmology
Review and update of central serous chorioretinopathy : Current Opinion in Ophthalmology Log …

Purpose: To measure the hyporeflective lumen in the choroid of patients with central serous
choroidopathy (CSC) and to compare the diameter with that of a control group. Methods: The …

Purpose To assess the 1-year outcome of half-dose verteporfin photodynamic therapy (PDT)
for patients with chronic central serous chorioretinopathy (CSC). Design Retrospective …

Photodynamic therapy (PDT) using verteporfin (Visudyne®; Bausch+ Lomb) is a treatment
that is widely used to elicit cell and tissue death. In ophthalmology, PDT targets choroidal …

Similar to ultrasound adapting soundwaves to depict the inner structures and tissues, optical
coherence tomography (OCT) utilizes low coherence light waves to assess characteristics in …

Purpose Central serous chorioretinopathy (CSCR) is an idiopathic disorder characterised by
detachment of the neurosensory retina due to serous fluid accumulation between the …

Purpose To compare the outcome between high-density subthreshold micropulse laser
(HSML) treatment and half-dose photodynamic therapy (PDT) in chronic central serous …